dr. woyach on the role of btk in cll
Published 10 years ago • 118 plays • Length 0:38Download video MP4
Download video MP3
Similar videos
-
1:39
dr. woyach on the role of acalabrutinib in cll
-
1:37
woyach on the safety profiles of btk inhibitors in cll
-
1:33
dr. woyach on ongoing research with btk inhibitors in cll
-
1:25
dr. woyach on the role of chemoimmunotherapy in cll
-
1:08
dr. woyach on the role of small molecule inhibitors in cll
-
1:17
dr. woyach on btk inhibition and the mechanism of action of ibrutinib
-
1:03
dr. woyach on the safety of acalabrutinib versus ibrutinib in cll
-
1:07
primary findings from the epcore cll-1 trial of epcoritamab in cll and rt
-
1:05
dr. woyach on the utility of time-limited therapies in cll
-
1:15
dr. flinn on the role of btk inhibitors in cll
-
1:14
evaluating the role of btk inhibitors in cll
-
1:17
dr. woyach on treatment challenges in cll
-
1:47
dr. woyach on ibrutinib resistance in cll
-
1:16
dr. woyach on ibrutinib and peripheral lymphocytosis in patients with chronic lymphocytic leukemia
-
3:25
btk inhibitors in cll: treatment selection
-
5:06
evolution of btk inhibitors in cll
-
0:55
dr. woyach on the results of the elevate-tn trial
-
1:20
dr. woyach on 3-year follow-up of acalabrutinib/obinutuzumab combo in cll
-
3:57
btk inhibitors in chronic lymphocytic leukemia